Core Insights - Baird Medical Investment Holdings Ltd. has officially launched its Microwave Ablation (MWA) technology in the Egyptian market with a successful procedure at Ain Shams Specialized Hospital [1][2][3] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [3] - The company is FDA 510(k)-certified and has a presence in over 30 prestigious hospitals in the United States, including Johns Hopkins Hospital and Columbia University Medical Center [3] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [3] Recent Developments - The first procedure in Egypt involved a bone ablation for a 30-year-old male patient, successfully achieving full ablation and significant pain relief [2] - This procedure demonstrates the versatility of Baird's MWA system, extending its application from soft tissue to musculoskeletal treatments [2][3] - The company aims to enhance global access to advanced, non-surgical solutions through strategic partnerships with leading academic institutions [3]
Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation